Gene Therapy Market Research and Forecast Report 2023-2028

1. Global Gene Therapy Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Gene Therapy Market Research Report: The latest report by IMARC, titled “Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” " finds that the global gene therapy market size reached US$ 4.4 Billion in 2022. Gene therapy refers to an advanced medical technique that involves modifying the genes inside the cells of the patient's body to treat or prevent the progression of the disease. It works by replacing a defective gene with a new, normal and healthy gene in a cell to cure the disease or improve the body's ability to fight it. It is also used to treat numerous chronic and genetic disorders in human beings that have no other cures. Nowadays, manufacturers are offering a wide variety of gene therapy products, including plasmid deoxyribonucleic acid (DNA), human gene-editing technology, patient-derived cellular gene therapy, viral vectors, and bacterial vectors, which is currently escalating their demand across the globe. Request Free Sample Report: https://www.imarcgroup.com/gene-therapy-market/requestsample

4. Report Description and Highlights Report Description Global Gene Therapy Market Trends: The rising prevalence of genetic and acquired diseases, such as cancer, diabetes, cardiovascular diseases (CVDs), cystic fibrosis, and acquired immunodeficiency syndrome (AIDS), represents the primary factor driving the market growth. Besides this, the expanding geriatric population that is more susceptible to developing such chronic health conditions has catalyzed the product demand. Additionally, there has been a significant increase in government support and funding for gene therapy research. Along with this, the growing awareness regarding the benefits of gene therapy and easy accessibility to healthcare facilities have accelerated the product adoption rate. Furthermore, several key players are engaging in research and development (R&D) activities and making heavy investments toward product innovations to gain a competitive edge. Moreover, the introduction of new gene therapy that provides a safer and non-addictive alternative to opioids in treating various chronic pain conditions, such as lower back pain and rare neuropathic pain disorders, has propelled the market growth. Other factors, including the increasing approvals of gene therapy products, favorable reimbursement policies, improving healthcare infrastructure, rising consumer healthcare expenditure, and technological advancements, are also providing a positive impact on the market growth. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, growing at a CAGR of 15.39% during 2023-2028. Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

5. Report Description and Highlights Report Description Market Summary: Gene Type Insights: • Antigen • Cytokine • Tumor Suppressor • Suicide Gene • Deficiency • Growth Factors • Receptors • Others Vector Type Insights: • Viral Vector • Adenoviruses • Lentiviruses • Retroviruses • Adeno-Associated Virus • Herpes Simplex Virus • Poxvirus

6. Report Description and Highlights Report Description • Vaccinia Virus • Others • Non-Viral Techniques • Naked and Plasmid Vectors • Gene Gun • Electroporation • Lipofection • Others Delivery Method Insights: • In-Vivo Gene Therapy • Ex-Vivo Gene Therapy Application Insights: • Oncological Disorders • Rare Diseases • Cardiovascular Diseases • Neurological Disorders • Infectious Disease • Others

7. Report Description and Highlights Report Description Regional Insights: • North America • United States • Canada • Asia-Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others

8. Report Description and Highlights Report Description • Latin America • Brazil • Mexico • Others • Middle East and Africa

9. Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • • Abeona Therapeutics Inc. Adaptimmune Therapeutics plc Adverum Biotechnologies Inc. Amgen Inc. Astellas Pharma Inc. Biogen Inc. Bluebird Bio Inc. Mustang Bio Inc. (Fortress Biotech Inc.) Novartis AG Orchard Therapeutics plc UniQure N.V. Voyager Therapeutics Inc. View Full Report with TOC & List of Figure: https://www.imarcgroup.com/gene-therapy-market

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com